Emil Pharmaceutical Industries Profile
Key Indicators
- Authorised Capital ₹ 34.15 Cr
- Paid Up Capital ₹ 21.33 Cr
- Company Age 38 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 224.73 Cr
- Satisfied Charges ₹ 63.50 Cr
- Revenue Growth 31.79%
- Profit Growth 101.63%
- Ebitda 91.28%
- Net Worth 56.18%
- Total Assets 35.97%
About Emil Pharmaceutical Industries
Emil Pharmaceutical Industries Private Limited (EPIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 May 1986 and has a history of 38 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 34.15 Cr and a paid-up capital of Rs 21.33 Cr.
The company currently has active open charges totaling ₹224.73 Cr. The company has closed loans amounting to ₹63.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Emil Pharmaceutical Industries Private Limited India is Nikita Sharma as COMPANY SECRETARY. Tushar Korday, Sumegha Patange, Manjiri Devdhar, and Two other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230MH1986PTC039809
- Company No.
039809
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Emil Pharmaceutical Industries Private Limited offer?
Emil Pharmaceutical Industries Private Limited offers a wide range of products and services, including Antipyretic Medication, Aspirin Tablets.
Who are the key members and board of directors at Emil Pharmaceutical Industries?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikita Sharma  | Company Secretary | 01-Jul-2023 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mayur Sirdesai | Director | 17-Apr-2023 | Current |
| Tushar Korday | Director | 13-May-1986 | Current |
| Sumegha Patange | Director | 24-Feb-2004 | Current |
| Manjiri Devdhar | Director | 24-Feb-2004 | Current |
| Abhijit Gole | Director | 19-Aug-2024 | Current |
Financial Performance of Emil Pharmaceutical Industries.
Emil Pharmaceutical Industries Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 31.79% increase. The company also saw a substantial improvement in profitability, with a 101.63% increase in profit. The company's net worth Soared by an impressive increase of 56.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emil Pharmaceutical Industries?
In 2022, Emil Pharmaceutical Industries had a promoter holding of 99.22% and a public holding of 0.78%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Globela Pharma Private LimitedMayur Sirdesai is a mutual person
Emil Holdings Private LimitedTushar Korday is a mutual person
Somerset Health Capital Advisors Private LimitedMayur Sirdesai is a mutual person
- Somerset Healthcare Investment Advisors Private Limited
Mayur Sirdesai is a mutual person
Emil Healthcare Private LimitedTushar Korday is a mutual person
- Sicp Investment Advisors India Llp
Mayur Sirdesai is a mutual person
Charges (Loans)
₹224.73 Cr
₹63.50 Cr
Charges Breakdown by Lending Institutions
- Others : 126.73 Cr
- Hdfc Bank Limited : 53.00 Cr
- Axis Bank Limited : 45.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2024 | Others | ₹25.00 Cr | Open |
| 20 Apr 2024 | Hdfc Bank Limited | ₹53.00 Cr | Open |
| 12 Feb 2024 | Others | ₹33.00 Cr | Open |
| 12 Feb 2024 | Others | ₹7.00 Cr | Open |
| 19 Oct 2023 | Axis Bank Limited | ₹45.00 Cr | Open |
How Many Employees Work at Emil Pharmaceutical Industries?
Emil Pharmaceutical Industries has a workforce of 60 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emil Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emil Pharmaceutical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
